Herbas VPB

Print
EN | LT
LT - COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE
EN - COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
C07K 16/2803 (2013.01)
A61K 39/00 (2006.01)
C07K 16/2818 (2013.01)
A61P 1/04 (2006.01)
A61K2039/507 (2013.01)
A61P 11/00 (2006.01)
C07K2317/76 (2013.01)
A61P 25/00 (2006.01)
A61P 1/04 (2018.01)
A61P 35/00 (2006.01)
A61P 11/00 (2018.01)
A61P 35/02 (2006.01)
A61P 25/00 (2018.01)
A61P 43/00 (2006.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3481866
(13) Kind of document T
(96) European patent application number 17740851.5
Date of filing the European patent application 2017-07-05
(97) Date of publication of the European application 2019-05-15
(45) Date of publication and mention of the grant of the patent 2024-07-24
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/040665
Date 2017-07-05
PCT application publication
(87) Number WO 2018/009507
Date 2018-01-11
Priority applications
(30) Number Date Country code
201662359073 P 2016-07-06 US
Inventors
(72)
DOYLE, Sean , US
SELBY, Mark, J. , US
CHADWICK, Eric , US
Grantee
(73) Bristol-Myers Squibb Company , Route 206 and Province Line Road, Princeton, NJ 08543, US
Title
(54) COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE
  COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE